Informational content only — PPARx is not a government program, medical provider, or insurer. Read full disclaimer.
Reference

Prescription Assistance Programs

How patient-assistance programs work, who runs them, who qualifies, and where to actually go to apply. PPARx does not enroll patients — this page is informational.

What you should know before you read this page

PPARx does not run a patient-assistance program and we do not enroll patients in one. This page is reference information about how PAPs work in the United States. Where to actually apply is at the bottom of this page — and we link to the programs themselves, not to an intermediary.

What is a Prescription Assistance Program?

“Prescription Assistance Program” — also called Patient Assistance Program, PAP, or sometimes “patient support program” — is a generic term for a program that lowers the cost of a specific prescription medicine for a specific group of patients.

There isn’t one PAP. There are hundreds of them, run by different organizations for different reasons:

The programs differ in who funds them, what medicines they cover, who qualifies, what paperwork is required, and how long the help lasts. Do not assume what’s true for one is true for any other.

What a manufacturer PAP typically covers

Manufacturer PAPs generally help patients who:

  1. Have been prescribed a specific brand-name medicine the manufacturer makes.
  2. Are uninsured, underinsured, or whose insurance doesn’t cover that medicine.
  3. Earn under a specified income threshold — frequently 400% to 500% of the federal poverty level, sometimes higher, sometimes lower.
  4. Are U.S. residents (some programs require U.S. citizenship; others accept residents).

When approved, the program usually provides the medication free or at very low cost for a defined period (commonly 12 months), with re-application required to continue. Many programs ship directly to your prescriber’s office or to a specialty pharmacy rather than to your home.

What manufacturer PAPs don’t typically cover

This is the part most marketing pages skip:

Foundation copay assistance — the Medicare-friendly path

If you’re on Medicare and your manufacturer PAP route is closed, the parallel path is independent foundations. These charities cover copays for specific conditions when funding is available. Funding opens and closes throughout the year — when the disease fund is open, you apply; when it’s closed, you wait or look for a different fund.

The major ones:

How to find the right program for a specific medication

The fastest, most accurate path is the manufacturer’s website for the medicine itself. Search for “[medication name] patient assistance” — almost every major manufacturer maintains a dedicated page (e.g. Ozempic → Novo Nordisk’s PAP page; Trulicity → Lilly Cares; Eliquis → Bristol Myers Squibb Patient Assistance Foundation).

Aggregator directories also help, especially when you don’t know the manufacturer:

What to gather before you apply

Most PAP applications ask for the same set of documents. Having them assembled saves you back-and-forth:

Application turnaround is usually 1–6 weeks. If the medicine is something you can’t go without, ask your prescriber whether bridge samples are available while the application is processed.

Common mistakes

A few patterns we see worth avoiding:

When PAPs aren’t the right path

PAPs aren’t a fit for everyone. If you’re insured and the medicine is on your plan’s formulary, your insurance — even with a copay — is usually the better answer than a PAP application. If the medicine is generic, a pharmacy discount program (GoodRx, Cost Plus Drugs, Amazon Pharmacy) is usually faster and the price is usually lower. If the issue is access in the first place — finding a clinician — a PAP doesn’t solve that; a community health center does.

A reminder

We are not the program. We don’t process applications, we don’t review eligibility, we don’t have a hotline. If a page on the internet that claims to be PPARx asks you for your Social Security number or insurance information to “evaluate eligibility,” it isn’t us — close the tab.

For questions about this page, email [email protected].